3M Company — Q2 2014 Form 10-Q
Business context and reporting period. Diversified global manufacturer operating through Industrial, Safety and Graphics, Electronics and Energy, Health Care, and Consumer segments. This unaudited quarterly report covers the quarter and six months ended June 30, 2014; comparisons are with the corresponding 2013 periods unless noted.
Financial performance and condition
| Metric | Q2 2014 | Six months 2014 |
|---|---|---|
| Net sales | $8.134 billion, up 4.9% | $15.965 billion, up 3.8% |
| Operating income | $1.856 billion, versus $1.702 billion | $3.572 billion, versus $3.348 billion |
| Operating margin | 22.8%, versus 22.0% | 22.4%, versus 21.8% |
| Net income attributable to 3M | $1.267 billion, versus $1.197 billion | $2.474 billion, versus $2.326 billion |
| Diluted EPS | $1.91, versus $1.71 | $3.70, versus $3.32 |
| Effective tax rate | 29.5%, versus 27.4% | 28.5%, versus 28.2% |
- Q2 organic local-currency sales grew 4.8%: organic volume contributed 3.5% and pricing 1.3%. All five segments grew organically. Currency translation had no net impact on worldwide Q2 sales; it reduced first-half sales growth by 1.0%.
- Q2 segment sales growth was led by Electronics and Energy (+6.2%), Health Care (+5.9%), and Industrial (+4.9%). Electronics and Energy operating income rose 23.4%; its margin increased to 20.6% from 17.7%. Health Care had the highest segment margin at 30.7%.
- Q2 margin improvement reflected higher prices, lower raw-material costs, lower pension costs, and volume leverage; strategic investment and foreign exchange were offsets. The company estimated currency effects reduced 3M-attributable net income by $25 million in Q2 and $54 million in the first half.
- Six-month operating cash flow was $2.732 billion, versus $2.673 billion. Capital spending was $634 million, producing company-defined free cash flow of $2.098 billion, versus $1.955 billion. Working-capital needs absorbed cash, principally through increases in receivables and inventory.
- At June 30, cash and equivalents were $2.125 billion; current and noncurrent marketable securities totaled $2.088 billion. Total debt was $6.973 billion and net debt, as defined by 3M, was $2.760 billion, compared with $1.219 billion at year-end 2013. Debt-to-total-capital increased to 28% from 25%.
- Working capital was $6.153 billion, up $918 million from year-end. Total assets were $33.970 billion and total equity was $17.846 billion.
Material changes and capital allocation
- 3M repurchased $3.134 billion of stock in the first half, versus $1.995 billion a year earlier, and paid $1.122 billion in dividends, versus $876 million. The new $12 billion repurchase authorization had approximately $9.2 billion remaining at June 30.
- In June, 3M issued $625 million of five-year notes at 1.625% and $325 million of 30-year notes at 3.875%. The five-year issuance was partly swapped to floating-rate exposure. The company reported zero commercial paper outstanding at quarter-end.
- 3M acquired health-care analytics provider Treo Solutions for $94 million net of cash acquired. In July, after quarter-end, it announced an approximately $885 million purchase of the remaining 25% of Sumitomo 3M Limited, expected to close September 1, 2014.
- Segment reporting was realigned, including a product-line transfer and changes within Electronics and Energy; prior-period segment figures were recast. In Q2, three Electronics and Energy divisions were combined into two.
Outlook, commentary, and risks
- Management expected 2014 capital spending of $1.5–$1.6 billion, reduced from a prior $1.7–$1.8 billion estimate, and gross share repurchases of $4.5–$5.0 billion. It planned $2–$4 billion of added leverage versus year-end 2013.
- Management forecast a 2014 effective tax rate of approximately 28%–29%, assuming reinstatement of the U.S. research and development tax credit. The company also expected defined-benefit and postretirement expense to fall by about $160 million pretax versus 2013, increasing EPS by about $0.15. No full-year revenue or EPS guidance is provided in the supplied filing text.
- 3M expected $100–$200 million of 2014 pension and postretirement contributions. Its investment priorities included R&D, commercialization, business transformation, and phased worldwide ERP implementation.
- Material contingencies include respirator-mask/asbestos claims (about 2,225 claimants; $153 million total reported liability and $47 million insurance receivable, including Aearo-related amounts), environmental matters, and product litigation. 3M recorded a $26 million judgment in the TransWeb patent/antitrust case and appealed in July. In an EDF product dispute, a court-appointed expert reported alleged damages exceeding €100 million; the opinion is not dispositive and remains subject to challenge. The company says it cannot estimate possible excess losses for several matters.
- Environmental exposure includes remediation and other environmental liabilities of $26 million and $45 million, respectively, with related insurance receivables of $11 million and $15 million. PFC regulatory and litigation outcomes remain uncertain.
- Other key risks include foreign exchange and economic conditions, especially currency effects in Venezuela; pricing and competition; raw-material availability and costs; legal and regulatory outcomes; pension assumptions; and execution, control, and cybersecurity risks associated with ERP deployment. 3M reported effective disclosure controls and no material control change during the quarter. Its interim financial statements received an accountant’s review, not an audit.
Important facts for investors to verify
- Whether organic sales momentum and margin gains persist as pricing benefits moderate in the second half and strategic investment spending continues.
- Execution of the stated capital-spending, buyback, leverage, tax-rate, and pension-contribution expectations; assess the implications for credit ratings and liquidity.
- Progress and final cost of the Sumitomo 3M minority-interest acquisition and the July Eurobond repayment funded primarily with commercial paper.
- Changes in asbestos, PFC/environmental, TransWeb, and EDF exposures, insurance recoveries, and any resulting cash or earnings charges.
- FX developments, including Venezuela, and the effect of working-capital requirements on cash conversion and free cash flow.